Kadcycla ADC - Potency Regulatory and Bioprocessing Concerns of ADCs - BioProcess InternationalBioProcess International
PDF) Site-Specific Antibody Conjugation for ADC and Beyond
Frontiers | Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism? | Oncology
ADC Pharmacokinetics Characterization - Creative Biolabs
Antibody–drug conjugates | Nature Reviews Drug Discovery
Antibody-drug conjugates—an emerging class of cancer treatment | British Journal of Cancer
Antibody-Drug Conjugates: The New Frontier of Chemotherapy
Comparison of Analytical Methods for Antibody-Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP.,Analytical Chemistry - X-MOL
Pharmacokinetic and Immunological Considerations for Expanding the Therapeutic Window of Next-Generation Antibody–Drug Conjugates | SpringerLink
Anti-Cancer ADC Drugs: 3 Design Elements, 10 Approved ADCs, Multiple Clinical Trials | Biochempeg
Antibody-drug conjugate - Wikipedia
CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001
PDF) Antibody–Drug Conjugates: Perspectives and Characterization
PDF) Linkers Having a Crucial Role in Antibody–Drug Conjugates
Assessing ADC Plasma Stability by LC-MS Methods | SpringerLink
Pharmaceuticals | Free Full-Text | Antibody–Drug Conjugates: The Last Decade | HTML
Computationally designed antibody–drug conjugates self-assembled via affinity ligands | Nature Biomedical Engineering
On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency | Scientific Reports
PDF) Analytical methods for physicochemical characterization of antibody drug conjugates
Conjugation methods for ADC development. ADC production using... | Download Scientific Diagram
Frontiers | The Analysis of Key Factors Related to ADCs Structural Design | Pharmacology
Cleavable linkers in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) DOI:10.1039/C8CS00676H
Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin
Proof of site-specificity of antibody-drug conjugates produced by chemical conjugation technology: AJICAP first generation - ScienceDirect
BTG-driven conjugation: Antibodies for medicine
